Affordable Access

Publisher Website

ANTILYMPHOCYTE GLOBULIN IN PATIENTS WITH RENAL ALLOGRAFTS FROM CADAVERIC DONORS:Late Results of a Controlled Trial

Authors
Journal
The Lancet
0140-6736
Publisher
Elsevier
Publication Date
Volume
302
Issue
7823
Identifiers
DOI: 10.1016/s0140-6736(73)93132-2
Disciplines
  • Medicine

Abstract

Abstract Late review of a controlled clinical trial of antilymphocyte globulin (A.L.G.) for adjuvant immunosuppression in recipients of renal allografts from cadaver donors shows previously reported improved early results for patients receiving A.L.G. therapy to be maintained with time.

There are no comments yet on this publication. Be the first to share your thoughts.